Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021

被引：62
|
作者：
Martinez-Baz, Ivan [1 ,2 ,3 ]
Miqueleiz, Ana [3 ,4 ]
Casado, Itziar [1 ,2 ,3 ]
Navascues, Ana [3 ,4 ]
Trobajo-Sanmartin, Camino [3 ,4 ]
Burgui, Cristina [1 ,2 ,3 ]
Guevara, Marcela [1 ,2 ,3 ]
Ezpeleta, Carmen [3 ,4 ]
Castilla, Jesus [1 ,2 ,3 ]
机构：
[1] Inst Salud Publ Navarra, Pamplona, Spain
[2] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain
[3] Navarra Inst Hlth Res IdiSNA, Pamplona, Spain
[4] Complejo Hosp Navarra, Dept Clin Microbiol, Pamplona, Spain
来源：
EUROSURVEILLANCE | 2021年 / 26卷 / 21期
基金：
欧盟地平线“2020”;
关键词：
D O I：
10.2807/1560-7917.ES.2021.26.21.2100438
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
COVID-19 vaccine effectiveness was evaluated in close contacts of cases diagnosed during January-April 2021. Among 20,961 contacts, 7,240 SARS-CoV-2 infections were confirmed, with 5,467 being symptomatic and 559 leading to hospitalisations. Non-brand-specific one and two dose vaccine effectiveness were respectively, 35% (95% confidence interval (CI): 25 to 44) and 66% (95% CI: 57 to 74) against infections, 42% (95% CI: 31 to 52) and 82% (95% CI: 74 to 88) against symptomatic infection, and 72% (95% CI: 47 to 85) and 95% (95% CI: 62 to 99) against COVID-19 hospitalisation. The second dose significantly increased effectiveness. Findings support continuing complete vaccination.
引用
收藏
页数：7
相关论文
共 50 条
  • [1] Effectiveness of 3 COVID-19 Vaccines in Preventing SARS-CoV-2 Infections, January-May 2021, Aragon, Spain
    del Cura-Bilbao, Alicia
    Lopez-Mendoza, Hector
    Chaure-Pardos, Armando
    Vergara-Ugarriza, Alberto
    Guimbao-Bescos, Joaquin
    EMERGING INFECTIOUS DISEASES, 2022, 28 (03) : 591 - 598
  • [2] Effectiveness of the COVID-19 vaccines on preventing symptomatic SARS-CoV-2 infections and hospitalizations in Southwestern Alaska, January-December 2021
    Lefferts, Brian
    Bruden, Dana
    Plumb, Ian D.
    Hodges, Ellen
    Bates, Elizabeth
    January, Gerald
    Bruce, Michael G.
    VACCINE, 2023, 41 (23) : 3544 - 3549
  • [3] COVID-19 vaccines efficacy in preventing or limiting SARS-CoV-2 infections
    Mattiuzzi, Camilla
    Lippi, Giuseppe
    JOURNAL OF INFECTION, 2022, 84 (05) : 726 - 727
  • [4] Effectiveness of mRNA COVID-19 Vaccines and Hybrid Immunity in Preventing SARS-CoV-2 Infection and Symptomatic COVID-19 Among Adults in the United States
    Feldstein, Leora R.
    Ruffin, Jasmine
    Wiegand, Ryan E.
    Borkowf, Craig B.
    James-Gist, Jade
    Babu, Tara M.
    Briggs-Hagen, Melissa
    Chappell, James
    Chu, Helen Y.
    Englund, Janet A.
    Kuntz, Jennifer L.
    Lauring, Adam S.
    Lo, Natalie
    Carone, Marco
    Lockwood, Christina
    Martin, Emily T.
    Midgley, Claire M.
    Monto, Arnold S.
    Naleway, Allison L.
    Ogilvie, Tara
    Saydah, Sharon
    Schmidt, Mark A.
    Schmitz, Jonathan E.
    Smith, Ning
    Sohn, Ine
    Starita, Lea
    Talbot, H. Keipp
    Weil, Ana A.
    Grijalva, Carlos G.
    JOURNAL OF INFECTIOUS DISEASES, 2025,
  • [5] Immunological memory to SARS-CoV-2 infection and COVID-19 vaccines
    Sette, Alessandro
    Crotty, Shane
    IMMUNOLOGICAL REVIEWS, 2022, 310 (01) : 27 - 46
  • [6] Efficacy and safety of four COVID-19 vaccines in preventing SARS-CoV-2 infection: A rapid review
    Moron-Duarte, Lina Sofia
    Chacon, Kelly Rocio
    Gutierrez, Maria Paula
    De la Hoz, Ilich Herbert
    Yomayusa, Nancy
    BIOMEDICA, 2022, 42 : 19 - 31
  • [7] Authors' response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection
    Harder, Thomas
    Koch, Judith
    Vygen-Bonnet, Sabine
    Kuelper-Schiek, Wiebe
    Pilic, Antonia
    Reda, Sarah
    Scholz, Stefan
    Wichmann, Ole
    EUROSURVEILLANCE, 2021, 26 (35)
  • [8] Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021
    Harderi, Thomas
    Kochi, Judith
    Vygen-Bonneti, Sabine
    Kuelper-Schieki, Wiebe
    Pilici, Antonia
    Redai, Sarah
    Scholzi, Stefan
    Wichmann, Ole
    EUROSURVEILLANCE, 2021, 26 (28)
  • [9] Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2
    Firouzabadi, Negar
    Ghasemiyeh, Parisa
    Moradishooli, Fatemeh
    Mohammadi-Samani, Soliman
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 117
  • [10] SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review
    Fathizadeh, Hadis
    Afshar, Saman
    Masoudi, Mahmood Reza
    Gholizadeh, Pourya
    Asgharzadeh, Mohammad
    Ganbarov, Khudaverdi
    Kose, Sukran
    Yousefi, Mehdi
    Kafil, Hossein Samadi
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2021, 188 : 740 - 750
12345